Patients Facing Retinal Vein Occlusion Challenges

Patients experiencing retinal vein occlusion often face significant vision impairment. This condition can lead to complications such as macular edema, affecting daily activities and quality of life. The recent FDA approval of high-dose Aflibercept offers new hope for these patients. It represents a potential shift in treatment protocols, aiming to improve outcomes for those affected. Understanding the implications of this approval is crucial for both patients and healthcare providers.